Search & Analyze

Popular Searches

Lenskart Solutions Ltd.

HealthcareMedical Equipment/Supplies/Accessories
₹689.70BSE0.17%

07 Sep, 4:01 PM

₹689.70
₹1.20L Cr
182.59
13.38
6.85%
₹697.00
₹684.50
₹694.75
₹355.70

Customise metrics bar

Price Performance

Peer Comparison

Name
Lenskart Solutions Ltd.

LENSKART

689.70182.591,19,664.260.00228.43273.43%2,714.1843.27%12.55
POLY MEDICUR

POLYMED

1,701.9054.7217,250.710.2185.27-8.39%525.3830.30%14.05
MOLBIO

MOLBIO

1,128.1078.0413,000.220.0052.74320.28%408.38309.57%19.79
3BBLACKBIO

3BBLACKBIO

1,525.0023.521,308.860.338.98-28.99%33.4950.62%26.03
LAXMIDENTL

LAXMIDENTL

197.7535.261,088.210.0010.3223.83%74.7013.87%24.97
GKB OPHTHA

GKB

67.0010.4133.770.001.85387.99%33.042.28%8.82

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

ParticularsSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
1,735.691,668.831,727.571,894.462,096.152,307.732,515.712,714.18
Expenses1,449.141,456.661,434.711,558.411,681.771,843.601,977.282,125.70
286.55212.17292.86336.05414.38464.13538.43588.48
16.51%12.71%16.95%17.74%19.77%20.11%21.40%21.68%
69.6432.11211.6941.2633.2635.0449.0368.48
Interest26.2034.4747.5141.0445.1748.7143.5453.19
195.75199.28215.14237.13253.41270.34287.51304.63
133.957.99240.7999.72148.00178.42254.19299.61
35.56%76.82%8.58%38.66%30.10%25.62%19.90%23.76%
85.471.85218.8960.08102.22131.03200.29221.84
11.080.022.840.781.320.761.151.28

Profit & Loss

consolidated figures in ₹ Crores · Annual

ParticularsFY 2021-22 (Mar)FY 2022-23 (Mar)FY 2023-24 (Mar)FY 2024-25 (Mar)FY 2025-26 (Mar)
No of Months12.0012.0012.0012.0012.00
INCOME :
1,502.713,788.035,427.706,652.528,814.04
1,502.713,788.035,427.706,652.528,814.04
EXPENDITURE :
Increase/Decrease in Stock-17.39-33.54-59.28-83.1747.88
Raw Material Consumed617.161,334.111,738.512,091.072,490.23
Power & Fuel Cost7.0520.5037.7858.23128.47
Employee Cost245.28717.561,086.491,378.752,043.55
Other Manufacturing Expenses34.82144.12189.24245.41342.22
General and Administration Expenses142.21379.92541.70650.67966.90
Selling and Distribution Expenses578.59907.021,157.971,223.88818.92
Miscellaneous Expenses9.6254.5761.4346.41115.19
1,617.343,524.244,753.855,611.256,953.35
Operating Profit (Excl OI)-114.63263.78673.851,041.271,860.69
115.63139.95182.17356.76174.30
1.01403.73856.021,398.032,034.99
Interest23.4383.28123.50211.66286.17
PBDT-22.43320.45732.521,186.371,748.82
85.39417.55672.24796.571,048.38
Profit Before Taxation & Exceptional Items-107.82-97.1060.28389.80700.44
Exceptional Income / Expenses-15.71
-107.82-101.1859.03385.36680.33
Provision for Tax-37.4269.1988.02179.38
-107.82-63.76-10.15297.34500.95
Extra items0.000.00
Minority Interest-4.23-7.31-1.75-7.34
Share of Associate5.51
Consolidated Net Profit-102.31-67.99-17.46295.59493.61
Profit Balance B/F-1,092.92-1,195.46-1,264.04-1,286.81-991.86
Appropriations-1,195.23-1,263.44-1,281.51-991.22-498.24
-13.39-8.90-2.273.832.84
Adjusted EPS-1.34-0.89-0.233.832.84

Balance Sheet

consolidated figures in ₹ Crores

ParticularsFY 2021-22 (Mar)FY 2022-23 (Mar)FY 2023-24 (Mar)FY 2024-25 (Mar)FY 2025-26 (Mar)
30.1632.52182.38321.43347.28
Share Warrants & Outstandings7.5111.7014.7021.8526.18
Total Reserves2,910.435,429.595,452.215,755.458,365.05
Reserve excluding Revaluation Reserve2,910.435,429.595,452.215,755.458,365.05
Revaluation reserve0.000.000.00
2,948.105,473.815,649.296,098.738,738.51
Minority Interest95.98106.66107.44113.23
Secured Loans262.95102.5979.2854.90
Unsecured Loans310.86165.52132.2578.67
Deferred Tax Assets / Liabilities96.98106.5870.034.05
Other Long Term Liabilities378.981,571.321,779.971,941.262,633.35
Long Term Provisions6.8562.3165.9292.02114.45
Total Non-Current Liabilities385.822,304.422,220.572,314.842,885.42
Trade Payables178.70577.23516.17739.96952.13
Other Current Liabilities162.00841.54828.86971.101,401.73
Short Term Borrowings19.0196.5282.1454.3317.68
Short Term Provisions6.3772.7482.88103.16136.02
Total Current Liabilities366.071,588.041,510.041,868.552,507.56
Total Liabilities3,699.999,462.249,486.5610,389.5514,244.72
Gross Block388.854,887.415,217.767,745.309,769.25
Less: Accumulated Depreciation132.29499.06683.211,512.302,028.08
Less: Impairment of Assets1.731.42
Net Block256.574,388.354,534.556,231.277,739.75
Capital Work in Progress129.94133.7470.83106.90111.89
Non Current Investments25.4036.6241.6550.01230.06
Long Term Investment25.4036.6241.6550.01230.06
Long Term Loans & Advances92.24244.05258.32349.39431.16
Other Non Current Assets847.7066.93177.5821.9461.42
Total Non-Current Assets1,747.745,548.896,049.266,759.528,574.29
Currents Investments1,022.96751.42961.56987.83341.04
Inventories232.37611.19688.081,081.441,037.00
Sundry Debtors85.55281.07341.40125.89174.72
Cash and Bank89.46986.66805.20864.881,543.68
Other Current Assets198.22261.21263.34124.32133.16
Short Term Loans and Advances323.701,021.80377.72445.682,440.83
Total Current Assets1,952.253,913.353,437.303,630.035,670.43
Net Current Assets (Including Current Investments)1,586.182,325.311,927.261,761.493,162.87
Total Assets3,699.999,462.249,486.5610,389.5514,244.72
Contingent Liabilities19.2219.2244.6345.8390.90
Total Debt19.01917.21497.15345.43218.53
382.80712.40709.2576.5850.17
Adjusted Book Value38.2871.2470.9376.5850.17

Cash Flow

consolidated figures in ₹ Crores

ParticularsFY 2021-22 (Mar)FY 2022-23 (Mar)FY 2023-24 (Mar)FY 2024-25 (Mar)FY 2025-26 (Mar)
No of Months12.0012.0012.0012.0012.00
-107.82-101.1859.03385.36680.33
Adjustment7.58381.72652.08642.601,138.31
Changes In working Capital-71.13-162.15-165.62308.4098.26
Cash Flow after changes in Working Capital-171.36118.40545.501,336.361,916.90
Cash Flow from Operating Activities-182.9894.74487.381,230.631,669.59
Cash Flow from Investing Activities-420.87-2,976.49158.68-265.87-2,724.80
Cash Flow from Financing Activitie604.202,776.70-721.77-534.781,200.52
Net Cash Inflow / Outflow0.36-105.04-75.71429.99145.31
Opening Cash & Cash Equivalents6.016.42291.83219.99654.21
Cash & Cash Equivalent on Amalgamation / Take over / Merger5.3998.26
Cash & Cash Equivalent of Subsidiaries under liquidations390.464.17
Effect of Foreign Exchange Fluctuations0.12-0.30-1.1675.52
Closing Cash & Cash Equivalent6.48291.83219.99654.21973.30

Ratios

Valuation

182.59
13.38
53.88
12.42
3.77
51.40

Profitability

6.85
12.55
4.07
21.11
5.68

Leverage & Liquidity

0.03
2.26
3.38

Returns

0.00
0.72

Shareholding Pattern

Numbers in percentages

ParticularsNov '25Dec '25Mar '26Jun '26
17.5717.5717.5517.53
74.1619.7119.7436.33
8.2662.7262.7146.14
82.4382.4382.4582.47
No. of Shareholders5,43,0641,28,5021,11,9731,35,967

Corporate Actions

Showing: All
DateTypeDetailsEx-DateRecord Date
2026-07-28Board Meeting Quarterly Results
2026-07-23AGM
2026-04-30Board Meeting Audited Results

Insider Trading

DatePersonCategoryTransaction TypeSharesValue (₹)

No insider trading data available.

Sector Overview

HealthcareMedical Equipment/Supplies/Accessories

Lenskart Solutions Ltd. operates in the Healthcare sector under the Medical Equipment/Supplies/Accessories industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Company Information

Industry

Medical Equipment/Supplies/Accessories

Founded

2008

Headquarters

New Delhi, Delhi

Group

Private

Chairman

Peyush Bansal

Managing Director

Peyush Bansal

Company Secretary

Ashish Kumar Srivastava

Face Value

₹2

CIN

L33100DL2008PLC178355

Key Management

9 members across the board and senior leadership

Ashish Kumar Srivastava

Company Secretary & Chief Compliance Officer

Peyush Bansal

Chairman & Managing Director, Chief Executive Officer

Neha Bansal

Executive Director

Amit Chaudhary

Executive Director

Jayesh Tulsidas Merchant

Non Executive Independent Director

Bijou Kurien

Non Executive Independent Director

Ashish Kashyap

Non Executive Independent Director

Sayali Karanjkar

Non Executive Independent Director

Anant Gupta

Non Independent & Non Executive Director

LENSKART Latest News

News

10 of 10 articles
COMPANY31 Aug 2026 · 15:38

Alpha Wave Global sells 1.69% stake in Lenskart Solutions

Alpha Wave Global has sold stake through open market transactions worth around Rs 1856.78 crore

EQUITY27 Aug 2026 · 10:01

Lenskart Solutions informs about disclosure

EQUITY19 Aug 2026 · 10:20

Lenskart Solutions gains as its JV incorporates step-down subsidiary

Upon incorporation, 95 per cent of the equity interest in Wenzhou Framekart Trade Co is held by BFT

COMPANY18 Aug 2026 · 18:20

Lenskart Solutions’ JV incorporates step-down subsidiary

Upon incorporation, 95 per cent of the equity interest in Wenzhou Framekart Trade Co is held by BFT

EQUITY13 Aug 2026 · 12:51

Lenskart Solutions surges on reporting over three-fold jump in Q1 consolidated net profit

The total consolidated income of the company has increased by 42.99% at Rs 2,782.66 crore for Q1FY27

COMPANY13 Aug 2026 · 12:41

Lenskart Solutions reports over three-fold jump in Q1 consolidated net profit

The total consolidated income of the company has increased by 42.99% at Rs 2,782.66 crore for Q1FY27

EQUITY14 Jul 2026 · 14:23

Lenskart Solutions informs about disclosure

COMPANY12 Jun 2026 · 14:58

Platinum Jasmine sells 2.3% stake in Lenskart Solutions

Platinum Jasmine A 2018 Trust has divested stake through an open market transaction worth Rs 1960 crore

COMPANY10 Jun 2026 · 10:30

Lenskart Solutions acquires additional 3% stake in Quantduo Technologies

The acquisition of additional shareholding in Quantduo is consistent with the company's strategic objective of consolidating its ownership in Quantduo

EQUITY10 Jun 2026 · 10:18

Lenskart Solutions informs about acquisition updates

LENSKART

₹689.70

-0.17%